Infusion of Off-the-Shelf Expanded Cord Blood Cells to Augment Cord Blood Transplant in Patients With Hematologic Malignancies NCT01175785 Accelerated Pha...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Childhood Acute...
Childhood Acute...
Childhood Chron...
Childhood Myelo...
Chronic Phase C...
de Novo Myelody...
Previously Trea...
Refractory Anem...
Refractory Anem...
Refractory Anem...
Relapsing Chron...
Secondary Myelo...
umbilical cord ...
fludarabine pho...
cyclophosphamid...
ex vivo-expande...
total-body irra...
cyclosporine
mycophenolate m...
laboratory biom...
6 Months - 45 Years Nohla Therapeutics, Inc. View Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation Followed by Donor Bone Marrow Transplant, Mycophenolate Mofetil, and Cyclosporine in Treating Patients With Fanconi Anemia NCT00453388 Acute Myeloid L...
de Novo Myelody...
Fanconi Anemia
Previously Trea...
Allogeneic Bone...
Cyclophosphamid...
Cyclosporine
Fludarabine Pho...
Laboratory Biom...
Mycophenolate M...
Nonmyeloablativ...
Total-Body Irra...
- Fred Hutchinson Cancer Center View Intensity Modulated Total Marrow Irradiation, Fludarabine Phosphate, and Melphalan in Treating Patients With Relapsed Hematologic Cancers Undergoing a Second Donor Stem Cell Transplant NCT02333162 Previously Trea...
Recurrent Adult...
Recurrent Adult...
Recurrent Hemat...
Fludarabine Pho...
Melphalan
Intensity-Modul...
Total Marrow Ir...
Allogeneic Hema...
Peripheral Bloo...
Allogeneic Bone...
Tacrolimus
Mycophenolate M...
Laboratory Biom...
18 Years - 75 Years University of Chicago View Hematopoietic Cell Transplantation for Pediatric Patients With Hematologic Malignancies NCT00795132 Acute Leukaemia
Chronic Disease
Leukemia
Myelodysplasia
Lymphoma
Busulfan
Anti-Thymocyte ...
Fludarabine
Cyclosporine
Mycophenolate m...
- 21 Years University of Utah View Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer NCT00723099 Acute Lymphobla...
Acute Myeloid L...
Aggressive Non-...
Chronic Myeloge...
Chronic Phase C...
Indolent Non-Ho...
Lymphoma
Mixed Phenotype...
Myelodysplastic...
Myeloproliferat...
Recurrent Chron...
Recurrent Folli...
Recurrent Lymph...
Recurrent Mantl...
Recurrent Margi...
Recurrent Plasm...
Recurrent Small...
Recurrent T-Cel...
Refractory Chro...
Refractory Chro...
Refractory Foll...
Refractory Hodg...
Refractory Lymp...
Refractory Mant...
Refractory Smal...
T-Cell Non-Hodg...
Allogeneic Hema...
Cyclophosphamid...
Cyclosporine
Fludarabine Pho...
Laboratory Biom...
Mycophenolate M...
Total-Body Irra...
Umbilical Cord ...
- 69 Years Fred Hutchinson Cancer Center View Yttrium-90 Anti-CD45 Monoclonal Antibody BC8 Followed by Donor Stem Cell Transplant in Treating Patients With High-Risk AML, ALL, or MDS NCT01300572 Chronic Myelomo...
Previously Trea...
Recurrent Adult...
Recurrent Adult...
Refractory Anem...
Secondary Acute...
Allogeneic Bone...
Allogeneic Hema...
Cyclosporine
Fludarabine Pho...
Indium In 111 A...
Laboratory Biom...
Mycophenolate M...
Peripheral Bloo...
Pharmacological...
Total-Body Irra...
Yttrium Y 90 An...
18 Years - Fred Hutchinson Cancer Center View Optimizing PTCy Dose and Timing NCT03983850 Graft Versus Ho...
Hematologic Neo...
Busulfan
Fludarabine
Cyclophosphamid...
Mycophenolate M...
Sirolimus
12 Years - 120 Years National Institutes of Health Clinical Center (CC) View Reduced Intensity, Partially HLA Mismatched BMT to Treat Hematologic Malignancies NCT01203722 Hematologic Mal...
Fludarabine
Cytoxan
Total Body Irra...
Allogeneic Bloo...
Peripheral Bloo...
Mycophenolate M...
Sirolimus
Tacrolimus
6 Months - 75 Years Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins View Targeting the IPA and Matching for the Non-Inherited Maternal Antigen for Haplo-Cord Transplantation NCT01810588 Hematologic Mal...
CliniMACS® CD34...
Fludarabine
Melphalan
anti-thymocyte ...
Rituximab
Total Body Irra...
Mycophenolate M...
Tacrolimus
18 Years - Weill Medical College of Cornell University View Combination Chemotherapy, Total Body Irradiation, and Donor Blood Stem Cell Transplant in Treating Patients With Secondary Myelofibrosis NCT03118492 Secondary Myelo...
Allogeneic Hema...
Cyclophosphamid...
Fludarabine
Glycosylated Re...
Laboratory Biom...
Melphalan
Mycophenolate M...
Tacrolimus
Total-Body Irra...
18 Years - 65 Years City of Hope Medical Center View A Two Step Approach to Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Hematologic Malignancies-Increasing GVT Effects Without Increasing Toxicity NCT03032783 Hematopoietic a...
Total-Body Irra...
Donor Lymphocyt...
Cyclophosphamid...
Tacrolimus
Mycophenolate M...
Allogeneic Hema...
18 Years - Thomas Jefferson University View Yttrium Y 90 Ibritumomab Tiuxetan, Fludarabine, Radiation Therapy, and Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma NCT00119392 B-cell Chronic ...
Nodal Marginal ...
Recurrent Adult...
Recurrent Adult...
Recurrent Adult...
Recurrent Adult...
Recurrent Adult...
Recurrent Adult...
Recurrent Adult...
Recurrent Grade...
Recurrent Grade...
Recurrent Grade...
Recurrent Mantl...
Recurrent Margi...
Recurrent Small...
Splenic Margina...
Waldenström Mac...
rituximab
cyclosporine
fludarabine pho...
mycophenolate m...
yttrium Y 90 ib...
peripheral bloo...
allogeneic hema...
total-body irra...
18 Years - Fred Hutchinson Cancer Center View Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Older Patients With Chronic Myeloid Leukemia NCT00003145 Accelerated Pha...
Childhood Chron...
Chronic Myeloge...
Chronic Phase o...
Recurrent Disea...
Fludarabine Pho...
Total-Body Irra...
Nonmyeloablativ...
Peripheral Bloo...
Cyclosporine
Mycophenolate M...
Therapeutic All...
Laboratory Biom...
- 74 Years Fred Hutchinson Cancer Center View Allo-HSCT With Alternative Donor in Treatment of Hematologic Malignancy NCT02487069 Acute Leukemia
Chronic Myeloid...
Myelodysplastic...
HSCT from MSD
HSCT from MUD
HSCT from HRD
Cyclosporin A
Methotrexate
Antithymocyte g...
Mycophenolate m...
18 Years - 60 Years Nanfang Hospital, Southern Medical University View Hematopoietic Stem Cell Transplantation in the Treatment of Infant Leukemia NCT00357565 Leukemia
Myelodysplastic...
Childhood Acute...
Recurrent Child...
Secondary Acute...
Childhood Acute...
Previously Trea...
Secondary Myelo...
Refractory Anem...
Refractory Anem...
Refractory Anem...
De Novo Myelody...
Childhood Myelo...
filgrastim
busulfan
cyclosporine
fludarabine pho...
melphalan
mycophenolate m...
umbilical cord ...
- 3 Years Masonic Cancer Center, University of Minnesota View Haploidentical Hematopoietic Stem Cell Transplantation Using A Novel Clofarabine Containing Conditioning Regimen For Patients With Refractory Hematologic Malignancies NCT00824135 Hematologic Mal...
Clofarabine
Stem Cell Trans...
OKT3
Thiotepa
Melphalan
Mycophenolate m...
Rituximab
G-CSF
- 21 Years St. Jude Children's Research Hospital View Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy NCT00303719 Kidney Cancer
Leukemia
Lymphoma
Multiple Myelom...
Plasma Cell Neo...
Myelodysplastic...
anti-thymocyte ...
cyclophosphamid...
cyclosporine
fludarabine
mycophenolate m...
stem cell trans...
total body irra...
filgrastim
- 75 Years Masonic Cancer Center, University of Minnesota View Umbilical Cord Blood T-Regulatory Cell Infusion Followed by Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Leukemia or Other Hematologic Diseases NCT00376519 Graft Versus Ho...
Leukemia
Lymphoma
Multiple Myelom...
Myelodysplastic...
Secondary Myelo...
cyclophosphamid...
cyclosporine
fludarabine pho...
mycophenolate m...
Treg cell infus...
umbilical cord ...
total-body irra...
18 Years - 45 Years Masonic Cancer Center, University of Minnesota View Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies NCT01341301 Hematologic Mal...
Total Body Irra...
Donor Lymphocyt...
Cyclophosphamid...
Tacrolimus
Mycophenolate m...
Allogeneic hema...
Laboratory biom...
18 Years - Thomas Jefferson University View Optimized Donor Selection, Nonmyeloablative BMT for B-cell Lymphomas With Post-transplantation Cy and Rituximab NCT00946023 Lymphoma
B-cell Lymphoma
Non Hodgkin Lym...
Chronic Lymphoc...
Fludarabine
Cyclophosphamid...
Total body irra...
Tacrolimus
Mycophenolate M...
Rituximab
Allogeneic Bone...
1 Year - 75 Years Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins View Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases NCT06013423 Acute Leukemia ...
Acute Lymphobla...
Acute Myeloid L...
Blastic Plasmac...
Hematopoietic a...
Mixed Phenotype...
Myelodysplastic...
Myeloproliferat...
Non-Hodgkin Lym...
Chronic Myeloid...
Biospecimen Col...
Bone Marrow Asp...
Cyclophosphamid...
Cyclosporine
Diagnostic Imag...
Echocardiograph...
Fludarabine Pho...
Multigated Acqu...
Mycophenolate M...
Survey Administ...
Thiotepa
Total-Body Irra...
Umbilical Cord ...
6 Months - 65 Years Fred Hutchinson Cancer Center View Haplo Peripheral Blood Sct In GVHD Prevention NCT04473911 GVHD
AML
ALL
MDS
MPN
CMML
Hodgkin Lymphom...
Non Hodgkin Lym...
Blood Stem Cell...
Graft Vs Host D...
Acute Myeloid L...
Acute Lymphobla...
Myelodysplastic...
Myeloproliferat...
Chronic Myelomo...
Chemosensitive ...
FLUDARABINE
CYCLOPHOSPHAMID...
TBI
Melphalan
Sirolimus
Mycophenolate m...
RGI-2001
CYCLOPHOSPHAMID...
18 Years - 80 Years Massachusetts General Hospital View Optimized Donor Selection, Nonmyeloablative BMT for B-cell Lymphomas With Post-transplantation Cy and Rituximab NCT00946023 Lymphoma
B-cell Lymphoma
Non Hodgkin Lym...
Chronic Lymphoc...
Fludarabine
Cyclophosphamid...
Total body irra...
Tacrolimus
Mycophenolate M...
Rituximab
Allogeneic Bone...
1 Year - 75 Years Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins View Busulfan, Cyclophosphamide, and Melphalan or Busulfan and Fludarabine Phosphate Before Donor Hematopoietic Cell Transplant in Treating Younger Patients With Juvenile Myelomonocytic Leukemia NCT01824693 Juvenile Myelom...
Allogeneic Hema...
Busulfan
Cyclophosphamid...
Fludarabine Pho...
Laboratory Biom...
Melphalan
Mycophenolate M...
Pharmacological...
Tacrolimus
3 Months - 18 Years Children's Oncology Group View Haploidentical Donor Hematopoietic Progenitor Cell and NK Cell Transplantation for Hematologic Malignancy NCT01807611 Leukemia
Lymphoma
Total Lymphoid ...
Fludarabine
Cyclophosphamid...
Thiotepa
Melphalan
HPC,A Infusion
TC-NK Infusion
G-CSF
Mesna
CliniMACS
Mycophenolate m...
- 21 Years St. Jude Children's Research Hospital View 90 Y-BC8-DOTA Monoclonal Antibody, Fludarabine Phosphate, and Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Multiple Myeloma NCT01503242 Plasma Cell Mye...
Refractory Plas...
Allogeneic Hema...
Cyclosporine
Fludarabine Pho...
Mycophenolate M...
Peripheral Bloo...
Total-Body Irra...
Yttrium Y 90 An...
18 Years - 65 Years Fred Hutchinson Cancer Center View Allogeneic Hematopoietic Stem Cell Transplantation (AlloSCT) Initial Salvage Therapy for Induction Failure Acute Myeloid Leukemia (AML) NCT02441803 Leukemia
Busulfan
Fludarabine
Clofarabine
Total Body Irra...
Thymoglobulin
Stem Cell Infus...
Cyclophosphamid...
Tacrolimus
Mycophenolate m...
Decitabine
Cytarabine
Idarubicin
18 Years - 60 Years M.D. Anderson Cancer Center View Haploidentical Hematopoietic Stem Cell Transplantation Using A Novel Clofarabine Containing Conditioning Regimen For Patients With Refractory Hematologic Malignancies NCT00824135 Hematologic Mal...
Clofarabine
Stem Cell Trans...
OKT3
Thiotepa
Melphalan
Mycophenolate m...
Rituximab
G-CSF
- 21 Years St. Jude Children's Research Hospital View Yttrium-90 Anti-CD45 Monoclonal Antibody BC8 Followed by Donor Stem Cell Transplant in Treating Patients With High-Risk AML, ALL, or MDS NCT01300572 Chronic Myelomo...
Previously Trea...
Recurrent Adult...
Recurrent Adult...
Refractory Anem...
Secondary Acute...
Allogeneic Bone...
Allogeneic Hema...
Cyclosporine
Fludarabine Pho...
Indium In 111 A...
Laboratory Biom...
Mycophenolate M...
Peripheral Bloo...
Pharmacological...
Total-Body Irra...
Yttrium Y 90 An...
18 Years - Fred Hutchinson Cancer Center View Fucosylated T Cells for Graft Versus Host Disease (GVHD) Prevention NCT02423915 Leukemia
Lymphoma
Rituximab
Fludarabine
Cyclophosphamid...
Total Body Radi...
Fucosylated Reg...
Cord Blood Infu...
Mycophenolate m...
Sirolimus
Bone Marrow Asp...
G-CSF
Non-Fucosylated...
18 Years - 80 Years M.D. Anderson Cancer Center View Myeloablative Haploidentical BMT With Post-transplant Cyclophosphamide for Pediatric Patients With Hematologic Malignancies NCT02120157 Myeloablative C...
HLA-mismatched ...
Graft Survival
Transplantation...
Cyclophosphamid...
TBI
Busulfan
Unmanipulated B...
Tacrolimus
Mycophenolate m...
6 Months - 25 Years Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins View Reduced-Intensity Conditioning for the Prevention of Treatment-Related Mortality in Patients Who Undergo a Hematopoietic Stem Cell Transplant NCT05031897 Acute Lymphobla...
Acute Myeloid L...
Aplastic Anemia
Chronic Lymphoc...
Chronic Myelomo...
Essential Throm...
Hematopoietic a...
Hodgkin Lymphom...
Myelodysplastic...
Myelofibrosis
Myeloid Leukemi...
Myeloid Neoplas...
Non-Hodgkin Lym...
Plasma Cell Mye...
Polycythemia Ve...
Small Lymphocyt...
Hematopoietic C...
Mycophenolate M...
Tacrolimus
Cyclophosphamid...
Total-Body Irra...
Donor Lymphocyt...
Fludarabine
Melphalan
18 Years - Thomas Jefferson University View Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer NCT00027820 Adult Acute Mye...
Childhood Acute...
Childhood Acute...
Childhood Myelo...
Childhood Renal...
Chronic Myelomo...
Clear Cell Rena...
de Novo Myelody...
Metastatic Rena...
Previously Trea...
Progression of ...
Recurrent Adult...
Recurrent Adult...
Recurrent Adult...
Recurrent Adult...
Recurrent Adult...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Refractory Anem...
Refractory Anem...
Refractory Chil...
Refractory Chro...
Renal Medullary...
Type 1 Papillar...
Type 2 Papillar...
Untreated Adult...
Untreated Adult...
Untreated Child...
Fludarabine Pho...
Total-Body Irra...
Peripheral Bloo...
Nonmyeloablativ...
Cyclosporine
Mycophenolate M...
- Fred Hutchinson Cancer Center View 2-Step Approach to Stem Cell Transplant in Treating Participants With Hematological Malignancies NCT03712878 Hematopoietic a...
Total-Body Irra...
Donor Lymphocyt...
Cyclophosphamid...
Allogeneic Hema...
Tacrolimus
Mycophenolate M...
18 Years - Thomas Jefferson University View Combination Chemotherapy, Total-Body Irradiation, Peripheral Stem Cell Transplantation, and Lymphocyte Infusion in Treating Patients With Stage IV Melanoma NCT00006233 Melanoma (Skin)
therapeutic all...
cyclosporine
fludarabine pho...
mycophenolate m...
peripheral bloo...
radiation thera...
18 Years - 64 Years Fred Hutchinson Cancer Center View Adoptive Immunotherapy in Relapsed Hematological Malignancy: Early GVHD Prophylaxis NCT02593123 Hodgkin's Lymph...
Lymphoid Leukem...
Lymphoma
Leukemia
Myeloma
Acute Lymphocyt...
Non Hodgkin Lym...
Chronic Lymphoc...
Multiple Myelom...
Chronic Myeloge...
Myelodysplastic...
Recurrent Acute...
Recurrent Hodgk...
Recurrent Non-H...
Recurrent Plasm...
Recurrent Chron...
Recurrent Chron...
Acute Myelogeno...
mycophenolate m...
Sargramostim
Filgrastim
18 Years - 74 Years Virginia Commonwealth University View Total Body Irradiation and Astatine-211-Labeled BC8-B10 Monoclonal Antibody for the Treatment of Nonmalignant Diseases NCT04083183 Non-Malignant N...
Astatine At 211...
Fludarabine
Cyclophosphamid...
Lapine T-Lympho...
Total-Body Irra...
Hematopoietic C...
Mycophenolate M...
Sirolimus
Bone Marrow Asp...
Biospecimen Col...
18 Years - 49 Years Fred Hutchinson Cancer Center View Minitransplants With HLA-matched Donors : Comparison Between 2 GVHD Prophylaxis Regimens NCT01428973 Graft-Versus-Ho...
Hematological M...
Mycophenolate m...
Sirolimus
16 Years - 75 Years University of Liege View Reduced Intensity Chemotherapy and Radiation Therapy Before Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies NCT02566304 Acute Myeloid L...
Acute Myeloid L...
Aplastic Anemia
Chronic Myelomo...
Hodgkin Lymphom...
Indolent Non-Ho...
Malignant Neopl...
Myelodysplastic...
Myeloproliferat...
Plasma Cell Mye...
Refractory Anem...
Refractory Anem...
Refractory Anem...
Refractory Cyto...
Refractory Cyto...
Fludarabine
Total-Body Irra...
T Cell-Depleted...
Cyclophosphamid...
Peripheral Bloo...
Allogeneic Hema...
Tacrolimus
Mycophenolate m...
Laboratory Biom...
18 Years - Thomas Jefferson University View Sequential, Related Donor Partial Liver Transplantation Followed by Bone Marrow Transplantation for Hepatocellular Carcinoma (HCC) NCT02702960 Fibrolamellar H...
Hepatocellular ...
Hepatocellular ...
living related ...
Total body irra...
Bone marrow tra...
Cyclophosphamid...
Mesna
Filgrastim
Tacrolimus
mycophenolate m...
Prednisone
Antithymocyte g...
fludarabine
16 Years - 65 Years Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins View Sirolimus, Cyclosporine, and Mycophenolate Mofetil in Preventing Graft-versus-Host Disease in Treating Patients With Blood Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant NCT01251575 Adult Acute Lym...
Adult Acute Mye...
Adult Diffuse L...
Adult Myelodysp...
Adult Non-Hodgk...
Aggressive Non-...
Childhood Acute...
Childhood Acute...
Childhood Diffu...
Childhood Myelo...
Childhood Non-H...
Chronic Lymphoc...
Chronic Lymphoc...
Chronic Phase C...
Hematopoietic a...
Mantle Cell Lym...
Plasma Cell Mye...
Prolymphocytic ...
Recurrent Chron...
Refractory Chro...
T-Cell Prolymph...
Waldenstrom Mac...
Recurrent Diffu...
Recurrent Hodgk...
Allogeneic Hema...
Cyclosporine
Fludarabine Pho...
Laboratory Biom...
Mycophenolate M...
Peripheral Bloo...
Sirolimus
Total-Body Irra...
- Fred Hutchinson Cancer Center View Decitabine and Total-Body Irradiation Followed By Donor Bone Marrow Transplant and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia NCT01707004 Acute Myeloid L...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
de Novo Myelody...
Previously Trea...
Recurrent Adult...
Secondary Acute...
decitabine
fludarabine pho...
busulfan
cyclophosphamid...
tacrolimus
mycophenolate m...
filgrastim
total-body irra...
allogeneic bone...
laboratory biom...
18 Years - 75 Years University of Wisconsin, Madison View Intensity Modulated Total Marrow Irradiation, Fludarabine Phosphate, and Melphalan in Treating Patients With Relapsed Hematologic Cancers Undergoing a Second Donor Stem Cell Transplant NCT02333162 Previously Trea...
Recurrent Adult...
Recurrent Adult...
Recurrent Hemat...
Fludarabine Pho...
Melphalan
Intensity-Modul...
Total Marrow Ir...
Allogeneic Hema...
Peripheral Bloo...
Allogeneic Bone...
Tacrolimus
Mycophenolate M...
Laboratory Biom...
18 Years - 75 Years University of Chicago View Total-Body Irradiation, Tacrolimus, and Mycophenolate Mofetil Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancers NCT00003572 Leukemia
Lymphoma
Multiple Myelom...
Myelodysplastic...
peripheral bloo...
mycophenolate m...
tacrolimus
allogeneic bone...
radiation thera...
18 Years - 70 Years Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins View Clofarabine and Low-Dose Total-Body Irradiation in Treating Patients With Acute Myeloid Leukemia Undergoing Donor Peripheral Blood Stem Cell Transplant NCT01252667 Acute Myeloid L...
Allogeneic Hema...
Clofarabine
Cyclosporine
Laboratory Biom...
Mycophenolate M...
Peripheral Bloo...
Pharmacological...
Total-Body Irra...
2 Years - Fred Hutchinson Cancer Center View TCR-α/β and CD19 Depleted Stem Cell Grafts From Haplo Donors for HSCT in Relapsed Lymphoma NCT02652468 Lymphoma
Fludarabine Pho...
Mesna
Cyclophosphamid...
Total nodal irr...
T Cell-Depleted...
Allogeneic Hema...
Peripheral Bloo...
Mycophenolate M...
Tacrolimus
Rituximab
18 Years - 75 Years University of Wisconsin, Madison View Shorter Course Tacrolimus After Nonmyeloablative, Related Donor BMT With High-dose Posttransplantation Cyclophosphamide NCT01342289 Hodgkin's Lymph...
Leukemia
Myelodysplastic...
Multiple Myelom...
Non Hodgkin's L...
Cyclophosphamid...
Fludarabine
Total body irra...
Mycophenolate M...
Tacrolimus 60
Tacrolimus 90
Tacrolimus 120
Bone marrow tra...
6 Months - 75 Years Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins View Cryopreserved MMUD BM With PTCy for Hematologic Malignancies NCT05170828 Acute Leukemia
Myelodysplastic...
T-lymphoblastic...
Acute Lymphocyt...
Acute Myeloid L...
Acute Biphenoty...
Acute Undiffere...
Cyclophosphamid...
Fludarabine
Total Body Irra...
Busulfan
Mesna
Sirolimus
Mycophenolate M...
Filgrastim
Cyclophosphamid...
Bone Marrow Tra...
18 Years - 70 Years Ossium Health, Inc. View Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic Malignancies NCT04959175 Hematologic Neo...
Mycophenolate M...
Allogeneic HSCT
Fludarabine
Sirolimus
Filgrastim
Cyclophosphamid...
Mesna
Total Body Irra...
12 Years - 85 Years National Institutes of Health Clinical Center (CC) View 211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome NCT03670966 Acute Lymphobla...
Acute Myeloid L...
Acute Myeloid L...
Chronic Myelomo...
Myelodysplastic...
Recurrent Acute...
Recurrent Acute...
Refractory Acut...
Refractory Acut...
Recurrent Mixed...
Refractory Mixe...
Hematopoietic a...
Astatine At 211...
Cyclophosphamid...
Total-Body Irra...
Peripheral Bloo...
Bone Marrow Tra...
Mycophenolate M...
Recombinant Gra...
Fludarabine Pho...
Tacrolimus
Bone Marrow Asp...
Biospecimen Col...
18 Years - 75 Years Fred Hutchinson Cancer Center View Reduced Intensity Haploidentical Transplantation for the Treatment of Primary or Secondary Myelofibrosis NCT04370301 Primary Myelofi...
Secondary Myelo...
Cyclophosphamid...
JAK Inhibitor
Fludarabine
Recombinant Gra...
Melphalan
Mycophenolate M...
Peripheral Bloo...
Tacrolimus
Total-Body Irra...
Computed Tomogr...
Magnetic Resona...
Bone Marrow Bio...
Bone Marrow Asp...
Biospecimen Col...
Echocardiograph...
Multigated Acqu...
18 Years - Fred Hutchinson Cancer Center View Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Total Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome NCT00119366 Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Childhood Myelo...
Chronic Myelomo...
Previously Trea...
Recurrent Adult...
Recurrent Child...
Refractory Anem...
Refractory Anem...
Refractory Anem...
Refractory Cyto...
Secondary Acute...
Secondary Myelo...
iodine I 131 mo...
fludarabine pho...
total-body irra...
allogeneic hema...
peripheral bloo...
cyclosporine
mycophenolate m...
laboratory biom...
16 Years - 50 Years Fred Hutchinson Cancer Center View Mycophenolate Mofetil in Combination With Standard of Care for the Treatment of Glioblastoma NCT05236036 Astrocytoma
Glioblastoma
Glioblastoma, I...
MGMT-Unmethylat...
Recurrent Gliob...
Mycophenolate M...
Quality-of-Life...
Radiation Thera...
Temozolomide
18 Years - Northwestern University View A Research Study of Bone Marrow Transplantation From Unrelated or Partially Matched Related Donors NCT01349101 Hematological M...
Total Body Irra...
Cyclophosphamid...
Tacrolimus
Mycophenolate m...
Fludarabine
Busulfan
Hematopoietic s...
18 Years - Thomas Jefferson University View Reduced Intensity Donor Peripheral Blood Stem Cell Transplant in Treating Patients With De Novo or Secondary Acute Myeloid Leukemia in Remission NCT00045435 Acute Myeloid L...
Adult Acute Meg...
Adult Acute Min...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Erythrole...
Adult Pure Eryt...
Secondary Acute...
nonmyeloablativ...
fludarabine pho...
total-body irra...
cyclosporine
mycophenolate m...
peripheral bloo...
55 Years - Fred Hutchinson Cancer Center View Low-Dose Total-Body Irradiation and Fludarabine Phosphate Followed by Unrelated Donor Stem Cell Transplant in Treating Patients With Fanconi Anemia NCT00093743 Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Childhood Acute...
Childhood Myelo...
Fanconi Anemia
Previously Trea...
fludarabine pho...
cyclosporine
total-body irra...
allogeneic bone...
allogeneic hema...
peripheral bloo...
mycophenolate m...
- Fred Hutchinson Cancer Center View Chemotherapy and Total-Body Irradiation Followed by Donor Umbilical Cord Blood Transplant, Cyclosporine, and Mycophenolate Mofetil in Treating Patients With Hematologic Cancer NCT00290641 Chronic Myelopr...
Leukemia
Lymphoma
Myelodysplastic...
filgrastim
graft-versus-tu...
cyclophosphamid...
cyclosporine
fludarabine pho...
mycophenolate m...
umbilical cord ...
radiation thera...
- 45 Years Masonic Cancer Center, University of Minnesota View Sirolimus, Cyclosporine, and Mycophenolate Mofetil in Preventing Graft-versus-Host Disease in Treating Patients With Blood Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant NCT01251575 Adult Acute Lym...
Adult Acute Mye...
Adult Diffuse L...
Adult Myelodysp...
Adult Non-Hodgk...
Aggressive Non-...
Childhood Acute...
Childhood Acute...
Childhood Diffu...
Childhood Myelo...
Childhood Non-H...
Chronic Lymphoc...
Chronic Lymphoc...
Chronic Phase C...
Hematopoietic a...
Mantle Cell Lym...
Plasma Cell Mye...
Prolymphocytic ...
Recurrent Chron...
Refractory Chro...
T-Cell Prolymph...
Waldenstrom Mac...
Recurrent Diffu...
Recurrent Hodgk...
Allogeneic Hema...
Cyclosporine
Fludarabine Pho...
Laboratory Biom...
Mycophenolate M...
Peripheral Bloo...
Sirolimus
Total-Body Irra...
- Fred Hutchinson Cancer Center View Autologous Peripheral Blood Stem Cell Transplant Followed by Donor Bone Marrow Transplant in Treating Patients With High-Risk Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia NCT01008462 B-Cell Prolymph...
Hypodiploidy
Loss of Chromos...
Plasma Cell Leu...
Progression of ...
Recurrent Adult...
Recurrent Adult...
Recurrent Child...
Recurrent Child...
Recurrent Chron...
Recurrent Plasm...
Recurrent Small...
Refractory Chil...
Refractory Chro...
Refractory Non-...
Refractory Plas...
Refractory Smal...
t(14;16)
t(4;14)
T-Cell Prolymph...
Waldenstrom Mac...
Allogeneic Bone...
Allogeneic Hema...
Autologous Hema...
Autologous-Allo...
Carmustine
Cyclophosphamid...
Cytarabine
Etoposide
Fludarabine Pho...
Laboratory Biom...
Melphalan
Mycophenolate M...
Peripheral Bloo...
Tacrolimus
Total-Body Irra...
- 75 Years Fred Hutchinson Cancer Center View Combination Chemotherapy, Donor Stem Cell Transplant, Tacrolimus, Mycophenolate Mofetil, and Cyclophosphamide in Treating Patients With Hematologic Cancer NCT00782379 Leukemia
Lymphoma
Myelodysplastic...
busulfan
cyclophosphamid...
fludarabine pho...
mycophenolate m...
tacrolimus
allogeneic hema...
peripheral bloo...
18 Years - 60 Years Northside Hospital, Inc. View Low-Dose Total-Body Irradiation and Fludarabine Phosphate Followed by Unrelated Donor Stem Cell Transplant in Treating Patients With Fanconi Anemia NCT00093743 Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Childhood Acute...
Childhood Myelo...
Fanconi Anemia
Previously Trea...
fludarabine pho...
cyclosporine
total-body irra...
allogeneic bone...
allogeneic hema...
peripheral bloo...
mycophenolate m...
- Fred Hutchinson Cancer Center View Total Marrow and Lymphoid Irradiation as Conditioning Regimen Before Hematopoietic Cell Transplantation in Patients With Myelodysplastic Syndrome or Acute Leukemia NCT04262843 Acute Lymphobla...
Acute Myeloid L...
High Risk Myelo...
Myelodysplastic...
Cyclophosphamid...
Fludarabine
Fludarabine Pho...
Granulocyte Col...
Hematopoietic C...
Intensity-Modul...
Mycophenolate M...
Tacrolimus
12 Years - 60 Years City of Hope Medical Center View NK Cells in Cord Blood Transplantation NCT01619761 Accelerated Pha...
Acute Biphenoty...
Acute Lymphobla...
Acute Myeloid L...
Chronic Phase C...
DS Stage II Pla...
DS Stage III Pl...
High Grade B-Ce...
ISS Stage II Pl...
ISS Stage III P...
Myelodysplastic...
Recurrent Acute...
Recurrent Acute...
Recurrent Chron...
Recurrent Hodgk...
Recurrent Non-H...
Recurrent Small...
Refractory Acut...
Refractory Chro...
Refractory Hodg...
Refractory Non-...
Refractory Smal...
Secondary Acute...
Therapy-Related...
Therapy-Related...
Allogeneic Hema...
Cyclophosphamid...
Fludarabine Pho...
Laboratory Biom...
Lenalidomide
Melphalan
Mycophenolate M...
Natural Killer ...
Rituximab
Tacrolimus
Total-Body Irra...
Umbilical Cord ...
- 75 Years M.D. Anderson Cancer Center View Mismatched Family Member Donor Transplantation for Children and Young Adults With High Risk Hematological Malignancies NCT00566696 Leukemia, Acute...
Leukemia, Myelo...
Leukemia, Myelo...
Juvenile Myelom...
Hemoglobinuria,...
Hodgkin Lymphom...
Lymphoma, Non-H...
Myelodysplastic...
CliniMACS
Stem cell trans...
Fludarabine
Thioplex®
L-phenylalanine...
Mycophenolate m...
Rituxan™
Alemtuzumab
Cyclophosphamid...
Anti-thymocyte ...
G-CSF
Muromonab
- 21 Years St. Jude Children's Research Hospital View HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis NCT06001385 Acute Lymphobla...
Acute Myeloid L...
Acute Leukemia
Myelodysplastic...
Chronic Myeloid...
Chronic Lymphoc...
Myeloproliferat...
Lymphoma
Chronic Myelomo...
Pro-Lymphocytic...
Myelofibrosis
Busulfan
Fludarabine
PBSC Hematopoie...
Post-Transplant...
Mesna
Tacrolimus
Mycophenolate M...
Patient Reporte...
Melphalan
Total-body irra...
Cyclophosphamid...
18 Years - Center for International Blood and Marrow Transplant Research View Haplo Peripheral Blood Sct In GVHD Prevention NCT04473911 GVHD
AML
ALL
MDS
MPN
CMML
Hodgkin Lymphom...
Non Hodgkin Lym...
Blood Stem Cell...
Graft Vs Host D...
Acute Myeloid L...
Acute Lymphobla...
Myelodysplastic...
Myeloproliferat...
Chronic Myelomo...
Chemosensitive ...
FLUDARABINE
CYCLOPHOSPHAMID...
TBI
Melphalan
Sirolimus
Mycophenolate m...
RGI-2001
CYCLOPHOSPHAMID...
18 Years - 80 Years Massachusetts General Hospital View Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies NCT01471067 Blood And Marro...
Leukemia
Lymphoma
Transplantation...
Transplantation...
Melphalan
Fludarabine
Mycophenolate m...
Tacrolimus
Cord Blood Infu...
Rituximab
ATG
Busulfan
Clofarabine
Total Body Irra...
1 Year - 80 Years M.D. Anderson Cancer Center View Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant NCT01231412 Acute Lymphobla...
Acute Myeloid L...
Aggressive Non-...
Chronic Lymphoc...
Diffuse Large B...
Hematopoietic a...
Indolent Non-Ho...
Mantle Cell Lym...
Myelodysplastic...
Myeloproliferat...
Prolymphocytic ...
Recurrent Chron...
Recurrent Plasm...
Refractory Chro...
Refractory Chro...
Refractory Hodg...
Small Lymphocyt...
T-Cell Chronic ...
Waldenstrom Mac...
Allogeneic Hema...
Cyclosporine
Fludarabine Pho...
Mycophenolate M...
Peripheral Bloo...
Sirolimus
Total-Body Irra...
- Fred Hutchinson Cancer Center View Reduce Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed Multiple Myeloma NCT04205240 Recurrent Plasm...
Allogeneic Hema...
Cyclophosphamid...
Daratumumab
Fludarabine
Melphalan
Mycophenolate M...
Tacrolimus
18 Years - 75 Years Ohio State University Comprehensive Cancer Center View Low-Dose Total-Body Irradiation and Fludarabine Phosphate Followed By Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Stage IV Kidney Cancer NCT00005851 Recurrent Renal...
Stage IV Renal ...
fludarabine pho...
total-body irra...
nonmyeloablativ...
cyclosporine
mycophenolate m...
peripheral bloo...
therapeutic all...
laboratory biom...
- 74 Years Fred Hutchinson Cancer Center View Yttrium-90 Anti-CD45 Monoclonal Antibody BC8 Followed by Donor Stem Cell Transplant in Treating Patients With High-Risk AML, ALL, or MDS NCT01300572 Chronic Myelomo...
Previously Trea...
Recurrent Adult...
Recurrent Adult...
Refractory Anem...
Secondary Acute...
Allogeneic Bone...
Allogeneic Hema...
Cyclosporine
Fludarabine Pho...
Indium In 111 A...
Laboratory Biom...
Mycophenolate M...
Peripheral Bloo...
Pharmacological...
Total-Body Irra...
Yttrium Y 90 An...
18 Years - Fred Hutchinson Cancer Center View Combination Chemotherapy, Total Body Irradiation, and Donor Blood Stem Cell Transplant in Treating Patients With Primary or Secondary Myelofibrosis NCT03426969 Primary Myelofi...
Secondary Myelo...
Cyclophosphamid...
Filgrastim
Fludarabine Pho...
Hematopoietic C...
Melphalan
Mycophenolate M...
Tacrolimus
Total-Body Irra...
18 Years - 70 Years M.D. Anderson Cancer Center View Combination Chemotherapy, Total-Body Irradiation, Peripheral Stem Cell Transplantation, and Lymphocyte Infusion in Treating Patients With Stage IV Melanoma NCT00006233 Melanoma (Skin)
therapeutic all...
cyclosporine
fludarabine pho...
mycophenolate m...
peripheral bloo...
radiation thera...
18 Years - 64 Years Fred Hutchinson Cancer Center View Fludarabine Phosphate and Total Body Irradiation Followed by a Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndromes or Myeloproliferative Disorders NCT00397813 Atypical Chroni...
Chronic Myelomo...
de Novo Myelody...
Essential Throm...
Myeloproliferat...
Paroxysmal Noct...
Polycythemia Ve...
Polycythemia Ve...
Primary Myelofi...
Refractory Anem...
Refractory Anem...
Refractory Anem...
Refractory Cyto...
Refractory Cyto...
Cyclosporine
Fludarabine Pho...
Laboratory Biom...
Mycophenolate M...
Nonmyeloablativ...
Peripheral Bloo...
Total-Body Irra...
50 Years - 75 Years Fred Hutchinson Cancer Center View Bendamustine With or Without Cyclophosphamide in Preventing GVHD in Patients Undergoing Stem Cell Transplant NCT04022239 Hematopoietic a...
Allogeneic Hema...
Bendamustine
Cyclophosphamid...
Filgrastim-sndz
Fludarabine
Melphalan
Mycophenolate M...
Rituximab
Tacrolimus
Total-Body Irra...
18 Years - 70 Years M.D. Anderson Cancer Center View Reduce Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed Multiple Myeloma NCT04205240 Recurrent Plasm...
Allogeneic Hema...
Cyclophosphamid...
Daratumumab
Fludarabine
Melphalan
Mycophenolate M...
Tacrolimus
18 Years - 75 Years Ohio State University Comprehensive Cancer Center View Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy NCT00303719 Kidney Cancer
Leukemia
Lymphoma
Multiple Myelom...
Plasma Cell Neo...
Myelodysplastic...
anti-thymocyte ...
cyclophosphamid...
cyclosporine
fludarabine
mycophenolate m...
stem cell trans...
total body irra...
filgrastim
- 75 Years Masonic Cancer Center, University of Minnesota View Chemotherapy in Patients With Relapsed Small Cell Lung Cancer in Combination With Allopurinol and MycoPhenolate (CLAMP Trial) NCT05049863 Small-cell Lung...
Small Cell Lung...
Mycophenolate M...
Allopurinol
Irinotecan
18 Years - Washington University School of Medicine View Chemotherapy, Radiation Therapy, Rituximab, and Umbilical Cord Blood Transplant in Treating Patients With B-Cell Non-Hodgkin's Lymphoma NCT00387959 Leukemia
Lymphoma
filgrastim
rituximab
cyclophosphamid...
cyclosporine
fludarabine pho...
mycophenolate m...
allogeneic hema...
umbilical cord ...
total-body irra...
18 Years - 70 Years Memorial Sloan Kettering Cancer Center View Trial of GVHD Prophylasxis With PTCy or Thymoglobulin in Unrelated SCT NCT02627573 Leukemia, Chron...
Myelodysplastic...
Leukemia, Myelo...
Unrelated allog...
Busulfan
Fludarabine mon...
Tacrolimus
Mycophenolate m...
Cyclophosphamid...
Thymoglobulin
18 Years - 75 Years St. Petersburg State Pavlov Medical University View